Tonghua Dongbao Pharmaceutical

Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Tonghua Dongbao Pharmaceutical Information

Geographic Data

Tonghua Dongbao Pharmaceutical headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$283M

Raised Total:

$283M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.

Contact Phone:

Contact Email:

Tonghua Dongbao Pharmaceutical went public on 8/24/1994 on the SSE

Listed Exchange:
SSE

IPO Date:
8/24/1994

Ticker Symbol:
600867

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
4/2017 POCTech Corporation Series B 14.5M
12/2015 AMOYTOP BIOTECH Funding Round 7.7M
4/2017 POCTech Corporation Series B 0
12/2015 AMOYTOP BIOTECH Funding Round 0
Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research